Ulf Hannelius Email
President & CEO . Diamyd Medical
Stockholm,
LocationPrimary Email
How to contact Ulf Hannelius
Join and see Ulf's contact info for free!Current Roles
Employees:
56Revenue:
$11.3MAbout
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development. Diamyd Medical develops the diabetes vaccine Diamyd®, an Antigen Based Therapy (ABT) based on the exclusively in-licensed GAD molecule. In-licensed technologies for GABA and Gliadin also have potential to become a key piece of the puzzle of a future solution to prevent, treat or cure autoimmune diabetes and other inflammation-related conditions. Diamyd Medical's share is traded on Nasdaq Stockholm First North, ticker DMYD B.Diamyd Medical Address
Kungsgatan 29Stockholm, null
SWE